Evidence map›Paper›PMID 14635791›Full record

ReviewJournal of mammary gland biology and neoplasia2003

Beta-catenin and Tcfs in mammary development and cancer.

Sarah Hatsell, Tracey Rowlands, Minoti Hiremath, Pamela Cowin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 207 citations in OpenAlex.

  1. Genes & diseases · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Exposure to brominated flame retardantsFrontiers in endocrinology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. The Molecular Basis of Wnt/International journal of cell biology · 2023
    Review
  10. The effect ofFrontiers in endocrinology · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. The proliferative effect of cortisol on bovine endometrial epithelial cells.Reproductive biology and endocrinology : RB&E · 2019
    Article
  15. Article
  16. Systematic analysis of breast atypical hyperplasia-associated hub genes and pathways based on text mining.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarah HatsellDepartment of Cell Biology, New York University School of Medicine, New York, New York 10016, USA.
Tracey Rowlands
Minoti Hiremath
Pamela Cowin
New York University · US

Funding

ROLE OF DESMOCOLLINS IN CELLULAR ADHESIONR01GM047429 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COWIN, PAMELA · 1992 to 2002
$1.0M
NIGMS NIH HHS GM47429
6 · The paper itself

Abstract

Beta-catenin regulates cell-cell adhesion and transduces signals from many pathways to regulate the transcriptional activities of Tcf/Lef DNA binding factors. Gene ablation and transgenic expression studies strongly support the concept that beta-catenin together with Lef/Tcf factors act as a switch to determine cell fate and promote cell survival and proliferation at several stages during mammary gland development. Mice expressing the negative regulator of Wnt/beta-catenin signaling (K14-Dkk) fail to form mammary buds, and those lacking Lef-1 show an early arrest in this process at stage E13.5. Stabilized deltaN89beta-catenin initiates precocious alveologenesis during pubertal development, and negative regulators of endogenous beta-catenin signaling suppress normal alveologenesis during pregnancy. Stabilized beta-catenin induces hyperplasia and mammary tumors in mice. Each of the beta-catenin-induced phenotypes is accompanied by upregulation of the target genes cyclin D1 and c-myc. Cyclin D1, however, is dispensable for tumor formation and the initiation of alveologenesis but is essential for later alveolar expansion.

Indexed as

Animalsbeta CateninBreast NeoplasmsCadherinsCell AdhesionCell DivisionCell SurvivalCyclin D1Cytoskeletal ProteinsDNA-Binding ProteinsFemaleHumansLymphoid Enhancer-Binding Factor 1Mammary Glands, AnimalMammary Glands, HumanMammary Neoplasms, Animalbeta CateninCadherinsCTNNB1 protein, humanCTNNB1 protein, mouseCyclin D1Cytoskeletal ProteinsDNA-Binding ProteinsLEF1 protein, humanLef1 protein, mouseLymphoid Enhancer-Binding Factor 1Mucin-1Proto-Oncogene Proteins c-mycTrans-ActivatorsTranscription Factors

Identifiers

PMID14635791
OpenAlexW1520332974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.